Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Paysign Targets $117M Revenue as Patient-Affordability Business Surges ↗
Via MarketBeat
Tickers PAYS
Exposures Product Safety
News headline image
University Findings Undermine Core Electrical Theory Behind Electroshock Therapy—Prompting CCHR's Renewed Calls for a Ban
Via 24-7 Press Release
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Possible Securities Law Violations Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Denver Regenerative Medicine Publishes Patient-Education Materials Defining "Rejuvenation Therapy"
Via Press Advantage
Exposures Product Safety
News headline image
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax ↗
Via Benzinga
Tickers PFE
Exposures COVID-19 Product Safety
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS Therapy to Phase 2 Development
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
News headline image
Ford Motor vs. Tesla: Analyzing Revenue Trends Between These Automotive Giants ↗
Via The Motley Fool
Topics Product Recall
Tickers F TSLA
Exposures Legal Product Safety
InvestorNewsBreaks – American Gene Technologies to Showcase AGT103-T at 2026 Disruptive Growth Conference
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
News headline image
When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges ↗
Via Benzinga
Exposures Product Safety
News headline image
Revolution Medicines Stock Trades Higher Following Landmark FDA Approval for Pancreatic Cancer Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
GLP Watchdog Launches Public Register of 500+ Online GLP-1 Sellers and 180+ FDA Warning Letters
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Vitamin K2 Market Size, Trends, and Growth Forecast to 2033 ↗
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Product Safety Supply Chain
News headline image
Winona Author Larry Kendrick Recounts Cold War-Era Army Service
Via PR Leap
Topics Product Recall
Exposures Legal Product Safety
News headline image
Johnson & Johnson Just Got a Big FDA Win ↗
Via The Motley Fool
Tickers JNJ
Exposures Product Safety
News headline image
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Via Newsfile
Topics Lawsuit
Tickers CAPR SAP
Exposures Financial Legal Product Safety
News headline image
Mesoblast H2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers ASX:MSB MESO
Exposures Financial Product Safety
News headline image
Kaplan Fox Alerts Investors to an Upcoming Deadline of September 28, 2026 in the Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Class Action
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Kessler Topaz Meltzer & Check, LLP Files a Class Action Lawsuit Against Volkswagen for Selling Vehicles With Defective Batteries That Catch Fire
Via NewMediaWire
Topics Lawsuit Product Recall
Tickers VLKAF VWAGY VWAPY
Exposures Financial Legal Product Safety
News headline image
Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall ↗
Via The Motley Fool
Topics Stocks
Tickers BSX MDT
Exposures Product Safety US Equities
News headline image
Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug ↗
Via Benzinga
Exposures Product Safety
News headline image
Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity? ↗
Via The Motley Fool
Tickers SNY
Exposures Product Safety
News headline image
Nasdaq 30’s VIVS, IGC, RIME, AIXI Stocks Now
Via AB Newswire
Topics Artificial Intelligence
Tickers AIXI IGC LLY RIME VIVS
Exposures Artificial Intelligence Product Safety
News headline image
INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
News headline image
FDA Approves 'Unprecedented' Pancreatic Cancer Drug ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
These Analysts Increase Their Forecasts On Jazz Pharmaceuticals ↗
Via Benzinga
Exposures Product Safety
GLP Watchdog Launches Public Register of 500+ Online GLP-1 Sellers and 180+ FDA Warning Letters
Via PulseBulletin.com
Exposures Product Safety
News headline image
Is It Too Late to Buy Eli Lilly? Billionaire Ken Griffin Doesn't Think So. He Nearly Quadrupled His Stake in the Pharma Stock in Q2. ↗
Via The Motley Fool
Tickers LLY
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.